Monday, April 30, 2012

Review and Giveaway for Modern Alternative Mama's Breast to Bib eBook!

OK - first off, let me start off with the Do's and Don't's.

In order to enter, you have a few options (all of which will be verified)  - please make a SEPARATE POST FOR EACH ADDITIONAL ENTRY:
1."Like" my Facebook page - Growing Up Naturally In Home Child Care (Leave your FB name for verification purposes, please.) - LEAVE A COMMENT BELOW STATING THAT YOU "LIKED" MY PAGE OR THAT YOU ARE AAF (ALREADY A FAN).
2. "Follow" me on my blog  (Leave your Blogger name for verification purposes, please.) LEAVE A COMMENT BELOW STATING THAT YOU "FOLLOWED" MY BLOG OR THAT YOU WERE ALREADY A FOLLOWER.
3. Check the list of recipes below and comment below which one you would most like to try!

ANY COMMENTS LEFT BELOW THAT ARE NOT ONE OF THE ABOVE THREE WILL NOT BE COUNTED AS AN ENTRY.

**** It would also be FANtastic of you to "Like" MAM's FB page (Please leave her a comment on her wall telling her that Growing Up Naturally In Home Child Care sent you!) - Modern Alternative Mama
or subscribe to her blog- http://www.modernalternativemama.com/blog/**
(Unfortunately, I cannot verify these as entries, these are just niceties as a "Thank you" to MAM for sponsoring this review/giveaway!)

YOU MUST LEAVE A WAY FOR ME TO CONTACT YOU! EMAIL ADDRESS, FB NAME (MAKE SURE TO FREQUENTLY CHECK YOUR "OTHER MESSAGES" FOLDER), SOMETHING...

WINNER MUST REPLY TO MY CONTACT TO THEM WITHIN 48 HOURS TO CLAIM THEIR PRIZE, OTHERWISE, THEIR PRIZE IS FORFEITED AND I WILL DRAW A NEW WINNER. WINNER WILL BE CHOSEN BY RANDOM.ORG BY COMMENT POST NUMBER.

This giveaway is not endorsed or sponsored by Facebook. All opinions are mine. I was not paid for my opinions, however, I did receive a copy of this book in exchange for them.


Ok - NOW HERE'S THE REVIEW!

This is the book that I am about to review. Please note that you can click on this picture if you wish to purchase this book.



You can also go through this link to go to MAM's store and view all of her books! Her books range in price from only $6.95 - $8.95! You can also purchase her books in bundle packages to save money! The best part is, they are ebooks so you can print the recipes while reading the book! :) All of her books are recipes books about eating a healthier diet and eating more Whole Foods, Real Foods, God Foods...whichever term you prefer.

In our household and in the in home child care that we run, we are very strict about the foods that we eat/serve. So MAM's recipes are all right up our alley!

In the Breast to Bib books, she features recipes for:


Baby Food
1. Guacamole
2. Pate
3. Yogurt
4. Scrambled Eggs
5. Veggies and Meat Dinner
6. Apple-Pear Sauce
7. Apple-Peach Sauce
8. Chocolate “Pudding”
9. Baby Custard


Toddler-Friendly
1. Pita Pizzas
2. Quesadillas
3. Popcorn
4. Toast with Apple Butter
5. Chicken Nuggets
6. Barbecue Sauce
7. Pigs in a Blanket
8. Mini-Meatballs
9. Easy Chocolate Pudding
10. Chicken and Bacon Salad
11. Popcorn Chicken
12. Cheese Sauce
13. Peanut Butter-Chocolate Chip
14. Granola Bars
15. Grilled Cheese Roll-ups
16. Chocolate Hazelnut Balls
17. Fruit Dip
18. Vegetable Dip
19. Fruit Juice Popsicles


As you can see, the recipes included are a wide range of choices! There are recipes in this book that are suitable for the entire family!

I absolutely loved this book. I would like to emphasize that the book is NOT just a cookbook of recipes! There is a LOT of info in there about feeding your baby and transitioning to food AND ONE OF MY FAVORITE PARTS - SHE EMPHASIZES BREASTFEEDING UNTIL AGE TWO! I wish more books would encourage that. There is also information about store bought versus homemade baby formula, she talks about low milk supply (causes and fixes!), food allergies, nutritional supplements, first foods, feeding schedules, finger foods, and more!


My husband, Michael, is the cook in the house. Therefore, he was the guinea pig when it comes to the actual making of the recipes. We provide child care out of our home and at this time, all of them are eating finger foods or "table food" so we were unable to try out any of the baby foods recipes.

Apple Butter in the food processor
We did however, try out the Toast with Apple Butter for breakfast for the kids. It was simple enough to make that I made it, not Michael! :) One batch lasted for about 10 servings which was great for us.

Toast with Apple Butter
Daniella eating her toast with apple butter



Later in the week, Michael also made Quesadillas. He added leftover chicken strips, diced bell peppers, and diced onions. The kids devoured them. I am guessing that cooking them in the coconut oil really gave it a good flavor!



Chicken and Veggie Quesadilla


 Another day this week, Michael made the Pita Pizzas. What child doesn't like pizza??? We also had a child present that day who is allergic to milk, eggs, and peanuts and we were able to accommodate that by simply not adding cheese to hers. :)

Pita Pizza Before Baking

Pita Pizza

Overall, Michael felt that the recipes were detailed and easy to follow and understand. He had no difficulties with any of the recipes we tried.  The kids all loved these meals. We tried these foods out with 5 different children, ranging in ages from 17 months to 10 years old, including our two children.


I highly recommend this book. I think it would make a great addition to any family's menu. I would especially recommend this book for first time moms, although any mom (especially a mom who may have previously store bought formula fed their child and is now planning to breastfeed another child). This book would make a great baby shower gift. It would also work well as a Mother's Day gift (WHICH IS RIGHT AROUND THE CORNER!!!) Another idea for this book would be a family with picky eaters. If your child is a pizza and chicken nuggets only type of child, at least this way, your child would have the opportunity to eat the healthiest varieties of such food.

The giveaway for this book begins NOW and ends on Friday, May 4th at 9 PM EST.

Tuesday, April 24, 2012

How to Brew Kombucha (Including a FREE Companion e-Book!

Ever wonder before how it is done? Want to learn to make your own? Want to know what kombucha is? (It is a Chinese probiotic tea that has been fermented.) I cannot WAIT to try this out - check out this YouTube video by Modern Alternative Mama on how to brew some up yourself! Don't forget, while you are there to look in the description of the video for a link for a FREE companion e-book!

Have You Checked Out Vitacost.com Yet?

If you have, but never purchased anything, or you haven't but have been meaning to - today is the day to go! Not only can you get a FREE $10 credit just by entering through this link but today only they have FREE SHIPPING for orders over $24. If you order is less than $24, SHIPPING IS ONLY $2.24! That is less than half of the cost of their regular S&H fees. (This is for standard shipping within the U.S. and the S&H offer expires at 11:59pm on 04/24/12) Shipping is super fast! This company amazes me with how many brand name items they carry -
Burt's Bees
Gladrags
California Baby
Jason
Bob's Red Mill
Hyland's
Avalon Organics
Annie's Naturals
Boudreaux's
Cascadian Farms
gDiapers
Ian's Natural Foods
Maranatha
and LOTS MORE!
http://www.vitacost.com

Update on the Maximized Living Advanced Plan Healing Diet

Today is Day 9. The end of last week was rough for me. I had a bit of a sore throat, so I couldn't eat much and survived mainly off of hot tea, smoothies and broth. Which was a good thing, because it shrunk my stomach some. Being a bigger sized woman, I am sure my stomach needed that to help me eat a better portion size. I also felt a huge change in my system as a response to the lack of sugar. I had dizzy spells, nausea, a weird metallic taste in my mouth and other symptoms related to the detox effects of this eating plan.

However, today is a new day. While I still have the odd metallic taste, the majority of the other symptoms have died down. And I feel great! I am energized, I want to get up and move, I have been walking a lot more, I have noticed a HUGE decrease in the amount of inflammation around a neck injury I suffered in a car accident 3+ years ago (which has DRASTICALLY CHANGED MY ONGOING DAILY PAIN LEVEL ASSOCIATED WITH IT!), Michael has noticed that his feet and knees do not bother him as much after standing fore long periods and I have noticed that my pants are fitting a LOT better, too. I haven't weighed myself yet, but I KNOW there has been some weight loss already.

A typical day for us with meals goes something like this:

A smoothie or a granny smith apple with almond butter for breakfast

A salad with some sort of protein in it for lunch

A smoothie or a granny smith apple with almond/peanut butter for snack (opposite of breakfast)

A meal surrounding mostly around a protein with veggies on the side for dinner

I have reached a point where I am having ZERO cravings for sweets. Which is HUGE for me. My friends and family know that I recently gave up ice cream for Lent. 40 days with no ice cream was pure torture for me. Seriously. I ate SO much other sweets trying to compensate for not eating ice cream that I actually gained 3 pounds during Lent. Sad. But all cravings are currently gone! This eating plan truly IS healing my body. I never had this part happen when I previously did this eating plan. I always wondered why. I think maybe it was because I was pregnant with Daniella and therefore had a constant need to intake calories for her. I sometimes have to remind myself to go eat on this plan. I do not have a huge amount of hunger. I really feel my body healing inside and I am so excited!

Monday, April 23, 2012

Parents - Newsletter Week of April 16th

Just a reminder that all activities are based on the number of children present each day, ages of the children present, and mood of the children.


April Newsletter


Week of April 16th


Monthly Thematic Unit – Spring Has Sprung!


Color of the Month – Purple


Song of the Week:


“Bug Song”
(Sung to "If You're Happy and You Know It")
Oh, I wish I were an eensy-weensy spider.
*clap, clap*
Yes, I wish I were an eensy-weensy spider.
*clap, clap*
I'd go "creepy-creepy-crawly" down your hall and up your "wall-y!"
Oh, I wish I were an eensy-weensy spider.
*Clap Clap* (clap hands twice)
Oh, I wish I were a yellow honeybee.
*clap, clap*
Yes, I wish i were a yellow honeybee.
*clap, clap*
I'd go "buzzy-buzzy-buzzy" and my stripes would all be fuzzy!
Oh, I wish I were a yellow honeybee.
*clap, clap*
Oh, I wish you were a wiggly caterpillar.
*clap, clap*
Yes, I wish I were a wiggly caterpillar.
*clap, clap*
I'd go "munchy-munchy-munchy." All the leaves would be my "lunch-y"!
Oh, I wish i were a wiggly caterpillar.
*clap, clap
Oh, I wish I were a small red army ant.
*clap, clap*
Yes, i wish i were a small red army ant.
*clap, clap*
I'd go "trompy-trompy-trompy" over hills and through the "swamp-y"!
Oh, I wish i were a small red army ant.
*clap, clap*
Oh, I wish i were a hungry little skeeter.
*clap, clap*
Yes, I wish i were a hungry little skeeter.
*clap, clap*
I'd go "bitey-bitey-bitey" when you went outside at "night- y"!
Oh, I wish i were a hungry little skeeter.




Book of the Week: The Grouchy Ladybug by Eric Carle


What We Did On Monday: We began our day by playing with our kitchen toys and our toy animals.
 Then we enjoyed Independent Reading Time (IRT) where we focused this week on returning our books to the book shelves when we are finished reading them. After that, I introduced the BOTW and the SOTW. Later we played with our baby dolls, built with our bumpy blocks, played sweetly with our dollhouse, used our fine motor skills with our chain links and played with our Bounce Back Penguin.


Special Enrichment for Monday: We played JumpStart Preschool on our computer and made a bug collage!


What We Did On Tuesday: We started our day off by playing building with our Wee Waffle Block Village and working on puzzles. Then we enjoyed IRT where we focused this week on returning our books to the book shelves when we are finished reading them. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our kitchen toys, baby dolls, explored our Laugh and Learn House, played on our indoor slide and with our toy animals.


Special Enrichment for Tuesday: We watched an Elmo movie called Music Works Wonders!


What We Did On Wednesday: We began our day by playing with our kitchen toys and building with our Lincoln Logs. Then we enjoyed IRT where we focused this week on returning our books to the book shelves when we are finished reading them. Then we read the BOTW and sang the SOTW. After that, we enjoyed playing with our shape sorters, dollhouse, animal toys, Mr. Potato Heads, indoor slide, Laugh and Learn Home, and chain links.

Special Enrichment for Wednesday: It was too rainy this morning to play in the water table! So we listened to classical music and nature sounds instead! :)


What We Did On Thursday: We started our day by playing with our kitchen toys and Mr. Potato Head.
Then we enjoyed IRT where we focused this week on returning our books to the book shelves when we are finished reading them. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our Little People playsets, built with our chain links, and played in our dollhouse.


Special Enrichment for Thursday: We watched a short Baby Mozart movie and listened to ''Greg and Steve" music!


What We Did On Friday: We began our day by playing with our large beads and building with our Legos.
 Then we enjoyed IRT where we focused this week on returning our books to the book shelves when we are finished reading them. Then we read the BOTW and sang the SOTW. After that, we enjoyed playing with our Little People playsets, electronic learning toys to help us learn our shapes, colors, numbers and letters, kitchen toys,chain links and dinosaurs.

Special Enrichment for Friday: We watched the movie A Bug's Life to learn more about how ants live. We also went on a Bug Hunt around the playroom to look for pictures of various bugs!


What We Did on Saturday: We started our day by playing with our baby dolls and building with our wooden blocks. Then we enjoyed IRT where we focused this week on returning our books to the book shelves when we are finished reading them. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our kitchen toys, and built with our alphabet blocks and our bristle blocks.

Special Enrichment on Saturday: We watched the movie Blue's Big Musical!

Saturday, April 21, 2012

COMING SOON - REVIEW AND GIVEAWAY FOR MODERN ALTERNATIVE MAMA'S "BREAST TO BIB" EBOOK!

This giveaway will start on Monday, April 30th!!! Keep watching! :) :) I am soooo excited to try these recipes out with the kids on their menu this week!

Tuesday, April 17, 2012

Yesterday was Day 1 of the Maximized Living Advanced Plan Healing Diet

First of all, I want to share some more info on exactly what all this eating plan involves, then I will share with you what we ate yesterday. (By the way, only Michael and I are doing this, not the children.)

Here is a basic synopsis, although there is some conflicting date that I have read between there and elsewhere. But it gives you a general idea as to how this works. Here is some more info. This is where we obtained the majority of the recipes we plan to use.

We did this eating plan back in January of 2010, starting less than 2 weeks after Michael began chiropractic care and I got pregnant with Daniella (after almost 3 years of trying) within about 3 weeks! Overall, during those 6 weeks, I lost about 25 lbs. (yes, during early pregnancy - although I didn't know I was pregnant yet!)


OK, now that you have some of the basics down...

A few things to bear in mind. We don't care for fish, except tuna, and only in moderation. We also do not care for eggs. So between the two of those, that limits us quite a bit. 

Yesterday's menu:

Breakfast:
(1) sliced granny smith apple (this is one of the conflicting things we read, but apparently ONLY this variety of apple and berries are the only fruit approved)
(2) tbsp of almond butter (we used Trader Joe's that has flax seed blended in!)

(Delicious!)

Lunch:
Salad with Grilled Chicken

Afternoon Snack:
(2) handfuls of various berries with 2 tbsp homemade whipped cream (took heavy whipping cream and used a mixer until it whipped up and added 1 tsp of stevia sweetener)

Dinner:
Black Bean Taco Dip with Chopped Veggies

AND I took a 3/4 mile walk yesterday. Just hope I can especially keep up with the exercise!

Monday, April 16, 2012

Have You Ever Presented Your OB/Midwife With a Birth Plan?

I didn't do one with Brandon - and really wish that I did because I am sure things would have turned out a LOT different if I had.
With Daniella, I did. And her birth was 99% of everything I wanted. :) I reviewed my birth plan during an interview before I switched care from an OB to a midwife. I fired my OB because he didn't like my birth plan. My midwife was fine with everything on my birth plan! So I switched to her and the story played out from there :) Basically, what I am saying is, birth plans are important - even if you plan on a scheduled c-section or induction!

Here is a link to a website that offers Free Birth Plans....which basically just guides you through writing your own. If you were to present a doctor or midwife with this full thing, they probably would only read half of it! :)

Parents - Newsletter Week of April 9th


Just a reminder that all activities are based on the number of children present each day, ages of the children present, and mood of the children.




April Newsletter




Week of  April 9th


Monthly Thematic Unit – Spring Has Sprung!


Color of the Month – Purple


Song of the Week:

“TINY TIM”
I had a little turtle, his name was Tiny Tim.
I put him in the bathtub, to see if he could swim.
He drank up all the water, he ate up all the soap.
And now he's sick in bed, with a bubble in his throat!
(Hiccup!)


Book of the Week:  The Foolish Tortoise by Richard  Buckley


What We Did On Monday: We began our day by playing with our toy animals and our baby dolls. Then we enjoyed Independent Reading Time (IRT) where we focused this week on taking turns sharing our books with our friends. After that, I introduced the BOTW and the SOTW. Later we played with our dollhouse and built with Lincoln Logs and Duplos.


Special Enrichment for Monday: We played our Chutes and Ladders computer game!


What We Did On Tuesday: We started our day off by playing on our indoor slide and exploring our Laugh and Learn Home. Then we enjoyed IRT where we focused this week on taking turns sharing our books with our friends. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our electronic learning toys to learn colors, shapes, numbers and letters, pretended to cook in our kitchen, drove our toy cars all around, played with our toy animals and our Bounce Back Penguin and played dress up with some beaded necklaces.


Special Enrichment for Tuesday: We played with our musical instruments while listening to music!


What We Did On Wednesday: We began our day by exploring our Laugh and Learn Home and playing on our indoor slide.Then we enjoyed IRT where we focused this week on taking turns sharing our books with our friends.Then we read the BOTW and sang the SOTW. After that, we enjoyed playing with our train set, building with our wooden alphabet blocks, playing in our kitchen and using our imagination with our Little People playsets.



Special Enrichment for Wednesday: It was too chilly this morning to play in the water table, but lucky for us, a friend brought a movie to share! So we watched The Letter Factory instead! :)


What We Did On Thursday: We started our day by playing with our trains and cooking in our kitchen. Then we enjoyed IRT where we focused this week on taking turns sharing our books with our friends. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our musical instruments, sorted with our shape sorters, played with our Little People. climbed up and down our indoor slide and in and out of our Laugh and Learn Home. We also played with our Lights and Sounds Show toy and our Bounce Back Penguin.


Special Enrichment for Thursday: We made Chocolate Inside-Out Strawberries - oh, my goodness, they were delicious!!! Everyone devoured theirs. We also decorated turtle cutouts using green colored pencils, green markers and green crayons.


What We Did On Friday: We began our day by playing with our kitchen toys and our baby dolls. Then we enjoyed IRT where we focused this week on taking turns sharing our books with our friends. Then we read the BOTW and sang the SOTW. After that, we enjoyed playing with our Little People and toy animals.

Special Enrichment for Friday: We watched the movie Antz and painted with the color purple!

What We Did on Saturday: No one came to play today.


Special Enrichment on Saturday: No one came to play today.

Being Green - 5 Crafts You Can Do With Your Toddler That Use Recyclable Materials!

I have a large bin that I keep with my art supplies. Inside, is full of scraps of paper, pompoms, popsicle sticks, sequins, scraps of ribbon, cotton balls, scraps of foam, toilet paper tubes, tissue paper and a whole lot more! We love to make something out of "nothing" around here!

Here is a great website with a few ideas for you to try at home!

Saturday, April 14, 2012

MAXIMIZED LIVING ADVANCED PLAN HEALING DIET

Michael and I are getting ready to do the Maximized Living Advanced Plan Healing Diet...starting next week. I am gathering recipes, making menus, making lists of ingredients for grocery shopping and more! I plan to do a mini series of blog posts about it, too. It is a 6 week plan...so keep an eye out for those blog posts - which will have a ton of info in them! :) This is a very intricate, very healing from within, very restrictive but worth it eating plan.

Vaccine Components and Safety Info

Ever wonder about vaccine ingredients? Efficacy (how effective it is)? Ever wonder about side effects? Ever wonder why your doctor never tells you these things??


AFLURIA Influenza Virus Vaccine (this package insert detail is from Nov. 2011) - This vaccine has been approved for ages 5+ - there is a different influenza vaccine for the younger crowd.
This vaccine only shows a 60% efficacy! You get this vaccine to not get the flu, right? And it is only effective 60% of the time?
6.3 Adverse Reactions Associated With Influenza Vaccination
Anaphylaxis has been reported after administration of AFLURIA. Egg protein can induce immediate
hypersensitivity reactions among persons who have severe egg allergy. Allergic reactions include hives,
angioedema, asthma, and systemic anaphylaxis (see Contraindications [4]).
The 1976 swine influenza vaccine was associated with an increased frequency of GBS. Evidence for a
causal relation of GBS with subsequent vaccines prepared from other influenza viruses is unclear. If
influenza vaccine does pose a risk, it is probably slightly more than one additional case per 1 million
persons vaccinated.
Neurological disorders temporally associated with influenza vaccination, such as encephalopathy, optic
neuritis/neuropathy, partial facial paralysis, and brachial plexus neuropathy, have been reported.
Microscopic polyangiitis (vasculitis) has been reported temporally associated with influenza vaccination.

 AFLURIA is prepared from influenza virus propagated in the allantoic fluid of embryonated
chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using continuous flow
zonal centrifugation. The purified virus is inactivated with beta-propiolactone, and the virus particles are
disrupted using sodium taurodeoxycholate to produce a ″split virion″. The disrupted virus is further purified
and suspended in a phosphate buffered isotonic solution.
AFLURIA is standardized according to USPHS requirements for the 2011-2012 influenza season and is
formulated to contain 45 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg
HA for each of the three influenza strains recommended for the 2011-2012 Northern Hemisphere influenza
season: A/California/7/2009, NYMC X-181 (H1N1), A/Victoria/210/2009, NYMC X-187 (H3N2) (an A/Perth/
16/2009-like strain), and B/Brisbane/60/2008.
Thimerosal, a mercury derivative, is not used in the manufacturing process for the single dose
presentations; therefore these products contain no preservative. The multi-dose presentation contains
thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.

A single 0.5 mL dose of AFLURIA contains sodium chloride (4.1 mg), monobasic sodium phosphate (80
mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride
(20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each 0.5 mL dose may also
contain residual amounts of sodium taurodeoxycholate (≤ 10 ppm), ovalbumin (≤ 1 mcg), neomycin sulfate
(≤ 3 nanograms [ng]), polymyxin B (≤ 0.5 ng), and beta-propiolactone (≤ 2 ng).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers
used for the multi-dose vial contain no latex.
(Emphasis of bolding is mine)



CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, 
Recombinant] (this package insert is from Feb 2012)


CERVARIX does not provide protection against disease due to all HPV types [see
Clinical Studies (14.3)].
 CERVARIX has not been demonstrated to provide protection against disease from
vaccine and non-vaccine HPV types to which a woman has previously been exposed through
sexual activity [see Clinical Studies (14.2)].
 Females should continue to adhere to recommended cervical cancer screening procedures
[see Patient Counseling Information (17)].
 Vaccination with CERVARIX may not result in protection in all vaccine recipients. 

 CERVARIX is available in vials and 2 types of prefilled syringes. One type of prefilled
syringe has a tip cap which may contain natural rubber latex and a plunger which does not
contain latex. The other type has a tip cap and a rubber plunger which contain dry natural latex
rubber. Use of these syringes may cause allergic reactions in latex-sensitive individuals. The vial
stopper does not contain latex. [See How Supplied/Storage and Handling (16).]




...37 deaths were reported during the 7.4 years of follow-up: 20 in subjects who
received CERVARIX (0.06%, 20/33,623) and 17 in subjects who received control (0.07%,
17/23,700). Causes of death among subjects were consistent with those reported in adolescent
and adult female populations. The most common causes of death were motor vehicle accident (5
subjects who received CERVARIX; 5 subjects who received control) and suicide (2 subjects
who received CERVARIX; 5 subjects who received control), followed by neoplasm (3 subjects
who received CERVARIX; 2 subjects who received control), autoimmune disease (3 subjects
who received CERVARIX; 1 subject who received control), infectious disease (3 subjects who
received CERVARIX; 1 subject who received control), homicide (2 subjects who received
CERVARIX; 1 subject who received control), cardiovascular disorders (2 subjects who received
CERVARIX), and death of unknown cause (2 subjects who received control). Among females
10 through 25 years of age, 31 deaths were reported (0.05%, 16/29,467 of subjects who received
CERVARIX and 0.07%, 15/20,192 of subjects who received control).


Sub-analyses were conducted to describe
pregnancy outcomes in 761 women [N = 396 for CERVARIX and N = 365 pooled control, HAV
360 EL.U., HAV 720 EL.U., and 500 mcg Al(OH)3] who had their last menstrual period within
30 days prior to, or 45 days after a vaccine dose and for whom pregnancy outcome was known.
The majority of women gave birth to normal infants (65.2% and 69.3% of recipients of
CERVARIX and control, respectively). Spontaneous abortion was reported in a total of 11.7% of
subjects (13.6% of recipients of CERVARIX and 9.6% of control recipients) and elective
termination was reported in a total of 9.7% of subjects (9.9% of recipients of CERVARIX and
9.6% of control recipients). Abnormal infant other than congenital anomaly was reported in a
total of 4.9% of subjects (5.1% of recipients of CERVARIX and 4.7% of control recipients) and
premature birth was reported in a total of 2.5% of subjects (2.5% of both groups). Other
outcomes (congenital anomaly, stillbirth, ectopic pregnancy, and therapeutic abortion) were
reported in 0.3% to 1.8% of pregnancies among recipients of CERVARIX and in 0.3% to 1.4%
of pregnancies among control recipients.
 It is not known whether the observed numerical imbalance in spontaneous abortions in
pregnancies which occurred around the time of vaccination is due to a vaccine-related effect.

 GARDASIL
[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) 
Vaccine, Recombinant] (this package insert is from April 2011)


CONTRAINDICATIONS-------------------------------
• Hypersensitivity, including severe  allergic reactions to yeast (a
vaccine component), or after a previous dose of GARDASIL. (4)

 Of the entire study population (29,323 individuals), 0.04% of the reported serious systemic adverse
reactions were judged to be vaccine related by the study investigator. The most frequently (frequency of 4
cases or greater with either GARDASIL, AAHS control, saline placebo, or the total of all three) reported
serious systemic adverse reactions, regardless of causality, were:
Headache [0.02% GARDASIL (3 cases) vs. 0.02% AAHS control (2 cases)],
Gastroenteritis [0.02% GARDASIL (3 cases) vs. 0.02% AAHS control (2 cases)],
Appendicitis [0.03% GARDASIL (5 cases) vs. 0.01% AAHS control (1 case)],
Pelvic inflammatory disease  [0.02% GARDASIL (3 cases) vs. 0.03% AAHS control (4 cases)],
Urinary tract infection [0.01% GARDASIL (2 cases) vs. 0.02% AAHS control (2 cases)],
Pneumonia [0.01% GARDASIL (2 cases) vs. 0.02% AAHS control (2 cases)],
Pyelonephritis [0.01% GARDASIL (2 cases) vs. 0.02% AAHS control (3 cases)],
Pulmonary embolism [0.01% GARDASIL (2 cases) vs. 0.02% AAHS control (2 cases)].
One case (0.006% GARDASIL; 0.0% AAHS control or saline placebo) of bronchospasm; and 2 cases
(0.01% GARDASIL; 0.0% AAHS control or saline placebo) of asthma were reported as serious systemic
adverse reactions that occurred following any vaccination visit.
In addition, there was 1 individual in the clinical trials, in the group that received GARDASIL, who
reported two injection-site serious adverse reactions (injection-site pain and injection-site joint movement
impairment).
Deaths in the Entire Study Population
Across the clinical studies, 40 deaths (GARDASIL N = 21 or 0.1%; placebo N = 19 or 0.1%) were
reported in 29,323 (GARDASIL N = 15,706; AAHS  control N = 13,023, saline placebo N = 594)
individuals (9- through 45-year-old girls and women; and 9- through 26-year-old boys and men). The
events reported were consistent with events expected in healthy adolescent and adult populations. The
most common cause of death was motor vehicle accident (5 individuals who received GARDASIL and 4
individuals who received AAHS control), followed by drug overdose/suicide (2 individuals who received
GARDASIL and 6 individuals who received AAHS control), gun shot wound (1 individual who received
GARDASIL and 3 individuals who received AAHS control), and pulmonary embolus/deep vein thrombosis
(1 individual who received GARDASIL and 1 individual who received AAHS control). In addition, there
were 2 cases of sepsis, 1 case of pancreatic cancer, 1 case of arrhythmia, 1 case of pulmonary
tuberculosis, 1 case of hyperthyroidism, 1 case of post-operative pulmonary embolism and acute renal
failure, 1 case of traumatic brain injury/cardiac arrest, 1 case of systemic lupus erythematosus, 1 case of
cerebrovascular accident, 1 case of breast cancer, and 1 case of nasopharyngeal cancer in the group
that received GARDASIL; 1 case of asphyxia, 1 case of acute lymphocytic leukemia, 1 case of chemical
poisoning, and 1 case of myocardial ischemia in the AAHS control group; and 1 case of medulloblastoma
in the saline placebo group.
Systemic Autoimmune Disorders in Girls and Women 9 Through 26 Years of Age
In the clinical studies, 9- through 26-year-old girls and women were evaluated for new medical
conditions that occurred over the course of follow-up. New medical conditions potentially indicative of a
systemic autoimmune disorder seen in the group that received GARDASIL or AAHS control or saline
placebo are shown in Table 9. This population includes all girls and women who received at least one
dose of GARDASIL or AAHS control or saline placebo, and had safety data available. GARDASIL
®
[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883616


 7 DRUG INTERACTIONS
7.1 Use with RECOMBIVAX HB
Results from clinical studies indicate that  GARDASIL may be administered concomitantly (at a
separate injection site) with RECOMBIVAX HB [hepatitis B vaccine (recombinant)] [see Clinical Studies
(14.9)].
7.2 Use with Menactra and Adacel
Results from clinical studies indicate that  GARDASIL may be administered concomitantly (at a
separate injection site) with Menactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide
Diphtheria Toxoid Conjugate Vaccine] and Adacel  [Tetanus Toxoid, Reduced Diphtheria Toxoid and
Acellular Pertussis Vaccine Adsorbed (Tdap)] [see Clinical Studies (14.10)].
7.3 Use with Hormonal Contraceptives
In clinical studies of 16- through 26-year-old women, 13,912 (GARDASIL N = 6952; AAHS control or
saline placebo N = 6960) who had post-Month 7 follow-up used hormonal contraceptives for a total of
33,859 person-years (65.8% of the total follow-up time in the studies).
In one clinical study of 24- through 45-year-old women, 1357 (GARDASIL N = 690; AAHS control N =
667) who had post-Month 7 follow-up used hormonal contraceptives for a total of 3400 person-years
(31.5% of the total follow-up time in the study). Use of hormonal contraceptives or lack of use of hormonal
contraceptives among study participants did not impair the immune  response in the per protocol
immunogenicity (PPI) population.
7.4 Use with Systemic Immunosuppressive Medications
Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic
drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses
to vaccines [see Use in Specific Populations (8.6)].  GARDASIL
®
[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883616
12
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Category B:
Reproduction studies have been performed in female rats at doses equivalent to the recommended
human dose and have revealed no evidence of impaired  female fertility or harm to the fetus due to
GARDASIL. There are, however, no adequate and well-controlled studies in pregnant women. Because
animal reproduction studies are not always predictive of human responses, GARDASIL should be used
during pregnancy only if clearly needed.  
An evaluation of the effect  of GARDASIL on embryo-fetal, pre- and postweaning development was
conducted using rats. One group of rats was administered GARDASIL twice prior to gestation, during the
period of organogenesis (gestation Day 6) and on lactation Day 7. A second group of pregnant rats was
administered GARDASIL during the period of organogenesis (gestation Day 6) and on lactation Day 7
only. GARDASIL was administered at 0.5 mL/rat/occasion (120 mcg total protein which is equivalent to
the recommended human dose) by intramuscular injection. No adverse effects on mating, fertility,
pregnancy, parturition, lactation,  embryo-fetal or pre- and postweaning development were observed.
There were no vaccine-related fetal malformations or other evidence of teratogenesis noted in this study.
In addition, there were no treatment-related effects on developmental signs, behavior, reproductive
performance, or fertility of the offspring.
Clinical Studies in Humans
In clinical studies, women underwent urine pregnancy testing prior to administration of each dose of
GARDASIL. Women who were found to be pregnant  before completion of a 3-dose regimen of
GARDASIL were instructed to defer completion of  their vaccination regimen  until resolution of the
pregnancy.
GARDASIL is not indicated for women 27 years of age or older. However, safety data in women 16
through 45 years of age was collected, and 3819 women (GARDASIL N = 1894 vs. AAHS control or
saline placebo N = 1925) reported at least 1 pregnancy each.
The overall proportions of pregnancies that resulted in an adverse outcome, defined as the combined
numbers of spontaneous abortion, late fetal death, and congenital anomaly cases out of the total number
of pregnancy outcomes for which an outcome was known (and excluding elective terminations), were
22.6% (446/1973) in women who received GARDASIL and 23.1% (460/1994) in women who received
AAHS control or saline placebo.
Overall, 55 and 65 women in the group that received GARDASIL or AAHS control or saline placebo,
respectively (2.9% and 3.4% of all women who reported a pregnancy in the respective vaccination
groups), experienced a serious adverse reaction during pregnancy. The most common events reported
were conditions that can result in Caesarean section (e.g., failure of labor, malpresentation, cephalopelvic
disproportion), premature onset of labor (e.g., threatened abortions, premature rupture of membranes),
and pregnancy-related medical problems (e.g., pre-eclampsia, hyperemesis). The proportions of
pregnant women who experienced such events were comparable between the groups receiving
GARDASIL and AAHS control or saline placebo.
There were 45 cases of congenital anomaly in pregnancies that occurred in women who received
GARDASIL and 34 cases of congenital anomaly in pregnancies that occurred in women who received
AAHS control or saline placebo.
Further sub-analyses were conducted to evaluate pregnancies with estimated onset within 30 days or
more than 30 days from administration of a dose of GARDASIL or AAHS control or saline placebo. For
pregnancies with estimated onset within 30 days of vaccination, 5 cases of congenital anomaly were
observed in the group that received GARDASIL compared to 1 case of congenital anomaly in the group
that received AAHS control or saline placebo.  The congenital anomalies seen in pregnancies with
estimated onset within 30 days of vaccination included pyloric stenosis, congenital megacolon, congenital
hydronephrosis, hip dysplasia, and club foot. Conversely, in pregnancies with onset more than 30 days
following vaccination, 40 cases of congenital anomaly were observed in the group that received GARDASIL
®
[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] 9883616
13
GARDASIL compared with 33 cases of congenital anomaly in the group that received AAHS control or
saline placebo.
Pregnancy Registry for GARDASIL
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., maintains a Pregnancy Registry to
monitor fetal outcomes of pregnant women exposed to GARDASIL. Patients and health care providers
are encouraged to report any exposure to GARDASIL during pregnancy by calling (800) 986-8999.
8.3 Nursing Mothers
Women 16 Through 45 Years of Age
It is not known whether GARDASIL is excreted in human milk. Because many drugs are excreted in
human milk, caution should be exercised when GARDASIL is administered to a nursing woman.
GARDASIL or AAHS control were given to a total of 1133 women (vaccine N = 582, AAHS control N =
551) during the relevant Phase III clinical studies.
Overall, 27 and 13 infants of women who received GARDASIL or AAHS control, respectively
(representing 4.6% and 2.4% of the total number of women who were breast-feeding during the period in
which they received GARDASIL or AAHS control, respectively), experienced a serious adverse reaction.
In a post-hoc analysis of clinical studies, a higher number of breast-feeding infants (n = 7) whose
mothers received GARDASIL had acute respiratory  illnesses within 30 days post vaccination of the
mother as compared to infants (n = 2) whose mothers received AAHS control.  

Vaccination does not eliminate the necessity for women to continue to undergo recommended
cervical cancer screening. Women who receive GARDASIL should continue to undergo cervical
cancer screening per standard of care.
• Recipients of GARDASIL should not discontinue anal cancer screening if it has been
recommended by a health care provider.
• GARDASIL has not been demonstrated to provide protection against disease from vaccine and
non-vaccine HPV types to which a person has previously been exposed through sexual activity.
• Since syncope has been reported following vaccination sometimes resulting in falling with injury,
observation for 15 minutes after administration is recommended.
• Vaccine information is required to be given with each vaccination to the patient, parent, or
guardian.
• Information regarding benefits and risks associated with vaccination.
• GARDASIL is not recommended for use in pregnant women.
• Importance of completing the immunization series unless contraindicated.
 
 INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis 
Vaccine Adsorbed)  (This package insert is from Nov. 2011)


5 WARNINGS AND PRECAUTIONS
5.1 Guillain-Barré Syndrome
 If Guillain-Barré syndrome occurs within 6 weeks of receipt of a prior vaccine containing
tetanus toxoid, the decision to give any tetanus toxoid-containing vaccine, including INFANRIX,
should be based on careful consideration of the potential benefits and possible risks. When a
decision is made to withhold tetanus toxoid, other available vaccines should be given, as
indicated.
5.2 Latex
 INFANRIX is available in vials and 2 types of prefilled syringes. One type of prefilled
syringe has a tip cap which may contain natural rubber latex and a plunger which does not
contain latex. The other type has a tip cap and a rubber plunger which contain dry natural latex
rubber. Use of these syringes may cause allergic reactions in latex sensitive individuals. The vial
stopper does not contain latex. [See How Supplied/Storage and Handling (16).]
5.3 Syncope
 Syncope (fainting) can occur in association with administration of injectable vaccines,
including INFANRIX. Syncope can be accompanied by transient neurological signs such as
visual disturbance, paresthesia, and tonic-clonic limb movements. Procedures should be in place
to avoid falling injury and to restore cerebral perfusion following syncope.
5.4 Adverse Events Following Prior Pertussis Vaccination
 If any of the following events occur in temporal relation to receipt of a pertussis-
3

 The diphtheria toxin is produced by growing Corynebacterium diphtheriae in Fenton
medium containing a bovine extract. Tetanus toxin is produced by growing Clostridium tetani in
a modified Latham medium derived from bovine casein. The bovine materials used in these
extracts are sourced from countries which the United States Department of Agriculture (USDA)
has determined neither have nor present an undue risk for bovine spongiform encephalopathy
(BSE). Both toxins are detoxified with formaldehyde, concentrated by ultrafiltration, and
purified by precipitation, dialysis, and sterile filtration.
 The acellular pertussis antigens (PT, FHA, and pertactin) are isolated from Bordetella
pertussis culture grown in modified Stainer-Scholte liquid medium. PT and FHA are isolated
from the fermentation broth; pertactin is extracted from the cells by heat treatment and
flocculation. The antigens are purified in successive chromatographic and precipitation steps. PT
is detoxified using glutaraldehyde and formaldehyde. FHA and pertactin are treated with
formaldehyde.
 Diphtheria and tetanus toxoids and pertussis antigens (PT, FHA, and pertactin) are
individually adsorbed onto aluminum hydroxide.
 Diphtheria and tetanus toxoid potency is determined by measuring the amount of
neutralizing antitoxin in previously immunized guinea pigs. The potency of the acellular
pertussis components (PT, FHA, and pertactin) is determined by enzyme-linked immunosorbent
assay (ELISA) on sera from previously immunized mice.
 Each 0.5-mL dose contains aluminum hydroxide as adjuvant (not more than 0.625 mg
aluminum by assay) and 4.5 mg of sodium chloride. Each dose also contains ≤100 mcg of
residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80).
 INFANRIX is available in vials and 2 types of prefilled syringes. One type of prefilled
syringe has a tip cap which may contain natural rubber latex and a plunger which does not
contain latex. The other type has a tip cap and a rubber plunger which contain dry natural latex
rubber. The vial stopper does not contain latex. [See How Supplied/Storage and Handling (16).]
 INFANRIX is formulated without preservatives

 Efficacy of a 3-dose primary series of INFANRIX has been assessed in 2 clinical studies.
 A double-blind, randomized, active Diphtheria and Tetanus Toxoids (DT)-controlled trial
conducted in Italy assessed the absolute protective efficacy of INFANRIX when administered at
2, 4, and 6 months of age. The population used in the primary analysis of the efficacy of
INFANRIX included 4,481 infants vaccinated with INFANRIX and 1,470 DT vaccinees. The
mean length of follow-up was 17 months, beginning 30 days after the third dose of vaccine.
After 3 doses, the absolute protective efficacy of INFANRIX against WHO-defined typical
pertussis (21 days or more of paroxysmal cough with infection confirmed by culture and/or
serologic testing) was 84% (95% CI: 76, 89). When the definition of pertussis was expanded to
13include clinically milder disease with respect to type and duration of cough, with infection
confirmed by culture and/or serologic testing, the efficacy of INFANRIX was calculated to be
71% (95% CI: 60, 78) against >7 days of any cough and 73% (95% CI: 63, 80) against ≥14 days
of any cough. Vaccine efficacy after 3 doses and with no booster dose in the second year of life
was assessed in 2 subsequent follow-up periods. A follow-up period from 24 months to a mean
age of 33 months was conducted in a partially unblinded cohort (children who received DT were
offered pertussis vaccine and those who declined were retained in the study cohort). During this
period, the efficacy of INFANRIX against WHO-defined pertussis was 78% (95% CI: 62, 87).
During the third follow-up period which was conducted in an unblinded manner among children
from 3 to 6 years of age, the efficacy of INFANRIX against WHO-defined pertussis was 86%
(95% CI: 79, 91). Thus, protection against pertussis in children administered 3 doses of
INFANRIX in infancy was sustained to 6 years of age.
 A prospective efficacy trial was also conducted in Germany employing a household
contact study design. In preparation for this study, 3 doses of INFANRIX were administered at 3,
4, and 5 months of age to more than 22,000 children living in 6 areas of Germany in a safety and
immunogenicity study. Infants who did not participate in the safety and immunogenicity study
could have received a DTwP vaccine or DT vaccine. Index cases were identified by spontaneous
presentation to a physician. Households with at least one other member (i.e., besides index case)
aged 6 through 47 months were enrolled. Household contacts of index cases were monitored for
incidence of pertussis by a physician who was blinded to the vaccination status of the household.
Calculation of vaccine efficacy was based on attack rates of pertussis in household contacts
classified by vaccination status. Of the 173 household contacts who had not received a pertussis
vaccine, 96 developed WHO-defined pertussis, as compared with 7 of 112 contacts vaccinated
with INFANRIX. The protective efficacy of INFANRIX was calculated to be 89% (95% CI: 77,
95), with no indication of waning of protection up until the time of the booster vaccination. The
average age of infants vaccinated with INFANRIX at the end of follow-up in this trial was
13 months (range 6 to 25 months). When the definition of pertussis was expanded to include
clinically milder disease, with infection confirmed by culture and/or serologic testing, the
efficacy of INFANRIX against ≥7 days of any cough was 67% (95% CI: 52, 78) and against
≥7 days of paroxysmal cough was 81% (95% CI: 68, 89). The corresponding efficacy of
INFANRIX against ≥14 days of any cough or paroxysmal cough were 73% (95% CI: 59, 82) and
84% (95% CI: 71, 91), respectively. 

 FluMist®
Influenza Vaccine Live, Intranasal
Intranasal Spray
2011-2012 Formula (This package insert is from May 2011)


FluMist is a vaccine indicated for the active immunization of individuals 2-49 years of age against
influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. (1)
- CONTRAINDICATIONS - - - - - - - - - - - - - - - - - - - - - - - - - - -
• Hypersensitivity to eggs, egg proteins, gentamicin, gelatin, or arginine, or life-threatening reactions
to previous influenza vaccination. (4.1)
• Concomitant aspirin therapy in children and adolescents. (4.2)
- - - - - - - - - - - - - - - - - - - - - - - - WARNINGS AND PRECAUTIONS - - - - - - - - - - - - - - - - - - - - - - - -
• Do not administer FluMist to children <24 months of age because of increased risk of hospitalization
and wheezing observed in clinical trials. (5.1)
• FluMist should not be administered to any individuals with asthma or children <5 years of age with
recurrent wheezing because of the potential for increased risk of wheezing post vaccination. (5.2)
• If Guillain-Barré syndrome has occurred with any prior influenza vaccination, the decision to give
FluMist should be based on careful consideration of the potential benefits and risks. (5.3)
• Data supporting the safety and effectiveness of FluMist administration in immunocompromised
individuals are limited. (5.4)
• Safety has not been established in individuals with underlying medical conditions predisposing them
to wild-type influenza infection complications. (5.5)
- - - - - - - - - - - - - - - - - - - - - - - - - - - - ADVERSE REACTIONS - - - - - - - - - - - - - - - - - - - - - - - - - - -
Most common adverse reactions (≥10% in FluMist and at least 5% greater than in control) are runny nose
or nasal congestion in all ages, fever >100°F in children 2-6 years of age, and sore throat in adults. (6.1)


 5 WARNINGS AND PRECAUTIONS
5.1 Risks in Children <24 Months of Age
Do not administer FluMist to children <24 months of age. In clinical trials, an increased risk of wheezing
post-vaccination was observed in FluMist recipients <24 months of age. An increase in hospitalizations
was observed in children <24 months of age after vaccination with FluMist. [See Adverse Reactions (6.1).]
5.2 Asthma/Recurrent Wheezing
FluMist should not be administered to any individuals with asthma or children <5 years of age with
recurrent wheezing because of the potential for increased risk of wheezing post vaccination unless the
potential benefit outweighs the potential risk.
Do not administer FluMist to individuals with severe asthma or active wheezing because these
individuals have not been studied in clinical trials.
5.3 Guillain-Barré Syndrome
If Guillain-Barré syndrome has occurred within 6 weeks of any prior influenza vaccination, the decision
to give FluMist should be based on careful consideration of the potential benefits and potential risks
[see also Adverse Reactions (6.2)].
5.4 Altered Immunocompetence
Data supporting the safety and effectiveness of FluMist administration in immunocompromised
individuals are limited to 174 individuals with HIV infection and 10 mild to moderately immunocompromised children and adolescents with cancer [see Clinical Studies (14.3)].
5.5 Medical Conditions Predisposing to Influenza Complications
The safety of FluMist in individuals with underlying medical conditions that may predispose them to
complications following wild-type influenza infection has not been established. FluMist should not be
administered unless the potential benefit outweighs the potential risk.
5.6 Management of Acute Allergic Reactions
Appropriate medical treatment and supervision must be available to manage possible anaphylactic
reactions following administration of the vaccine [see Contraindications (4.1)].
5.7 Limitations of Vaccine Effectiveness
FluMist may not protect all individuals receiving the vaccine.
6 ADVERSE REACTIONS
FluMist is not indicated in children <24 months of age. In a clinical trial, among children 6-23 months of
age, wheezing requiring bronchodilator therapy or with significant respiratory symptoms occurred in
5.9% of FluMist recipients compared to 3.8% of active control (injectable influenza vaccine made by
Sanofi Pasteur Inc.) recipients (Relative Risk 1.5, 95% CI: 1.2, 2.1). Wheezing was not increased in
children ≥24 months of age.
Hypersensitivity, including anaphylactic reaction, has been reported post-marketing.
[See Warnings and Precautions (5.1) and Adverse Reactions (6.1, 6.2).]
6.1 Adverse Reactions in Clinical Trials
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed
in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trials of another
vaccine and may not reflect the rates observed in practice.
A total of 9537 children and adolescents 1-17 years of age and 3041 adults 18-64 years of age received
FluMist in randomized, placebo-controlled Studies D153-P501, AV006, D153-P526, AV019, and AV009
described below. In addition, 4179 children 6-59 months of age received FluMist in Study MI-CP111, a
randomized, active-controlled trial. Among pediatric FluMist recipients 6 months-17 years of age, 50%
were female; in the study of adults, 55% were female. In MI-CP111, AV006, D153-P526, AV019, and
AV009, subjects were White (71%), Hispanic (11%), Asian (7%), Black (6%), and Other (5%), while in
D153-P501, 99% of subjects were Asian.
Adverse Reactions in Children and Adolescents
In a placebo-controlled safety study (AV019) conducted in a large Health Maintenance Organization
(HMO) in children 1-17 years of age (n = 9689), an increase in asthma events, captured by review of
diagnostic codes, was observed in children <5 years of age (Relative Risk 3.53, 90% CI: 1.1, 15.7). This
observation was prospectively evaluated in Study MI-CP111.
In MI-CP111, an active-controlled study, increases in wheezing and hospitalization (for any cause) were
observed in children <24 months of age, as shown in Table 1.

 8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Category C
Animal reproduction studies have not been conducted with FluMist. It is not known whether FluMist can
cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. FluMist
should be given to a pregnant woman only if clearly needed.
The effect of the vaccine on embryo-fetal and pre-weaning development was evaluated in a developmental
toxicity study using pregnant rats receiving the frozen formulation. Groups of animals were administered
the vaccine either once (during the period of organogenesis on gestation day 6) or twice (prior to
gestation and during the period of organogenesis on gestation day 6), 250 microliter/rat/occasion
(approximately 110-140 human dose equivalents), by intranasal instillation. No adverse effects on
pregnancy, parturition, lactation, embryo-fetal or pre-weaning development were observed. There were
no vaccine-related fetal malformations or other evidence of teratogenesis noted in this study.
8.3 Nursing Mothers
It is not known whether FluMist is excreted in human milk. Therefore, as some viruses are excreted in
human milk, caution should be exercised if FluMist is administered to nursing mothers.
8.4 Pediatric Use
Safety and effectiveness of the vaccine has been demonstrated for children 2 years of age and older with
reduction in culture-confirmed influenza rates compared to active control (injectable influenza vaccine
made by Sanofi Pasteur Inc.) and placebo [see Clinical Studies (14.1)]. FluMist is not approved for use
in children <24 months of age. FluMist use in children <24 months has been associated with increased
risk of hospitalization and wheezing in clinical trials [see Warnings and Precautions (5.1) and Adverse
Reactions (6.1)].
8.5 Geriatric Use
FluMist is not approved for use in individuals ≥65 years of age. Subjects with underlying high-risk
medical conditions (n = 200) were studied for safety. Compared to controls, FluMist recipients had a
higher rate of sore throat.
8.6 Use in Individuals 50-64 Years of Age
FluMist is not approved for use in individuals 50-64 years of age. In Study AV009, effectiveness was not
demonstrated in individuals 50-64 years of age (n = 641). Solicited adverse events were similar in type
and frequency to those reported in younger adults.


 Specific pathogen-free (SPF) eggs are inoculated with each of the reassortant strains and incubated to
allow vaccine virus replication. The allantoic fluid of these eggs is harvested, pooled, and then clarified
by filtration. The virus is concentrated by ultracentrifugation and diluted with stabilizing buffer to obtain
the final sucrose and potassium phosphate concentrations. Ethylene diamine tetraacetic acid (EDTA) is
added to the dilution buffer for H3N2 strains. The viral harvests are then sterile filtered to produce the
monovalent bulks. Each lot is tested for ca, ts, and att phenotypes and is also tested extensively by in vitro
and in vivo methods to detect adventitious agents. Monovalent bulks from the three strains are
subsequently blended and diluted as required to attain the desired potency with stabilizing buffers to
produce the trivalent bulk vaccine. The bulk vaccine is then filled directly into individual sprayers for nasal
administration.
Each pre-filled refrigerated FluMist sprayer contains a single 0.2 mL dose. Each 0.2 mL dose contains
10
6.5-7.5
FFU of live attenuated influenza virus reassortants of each of the three strains: A/California/7/2009
(H1N1), A/Perth/16/2009 (H3N2), and B/Brisbane/60/2008. Each 0.2 mL dose also contains
0.188 mg/dose monosodium glutamate, 2.00 mg/dose hydrolyzed porcine gelatin, 2.42 mg/dose
arginine, 13.68 mg/dose sucrose, 2.26 mg/dose dibasic potassium phosphate, 0.96 mg/dose monobasic
potassium phosphate, and <0.015 mcg/mL gentamicin sulfate. FluMist contains no preservatives.

 14.5 Shedding Studies
FluMist contains live attenuated influenza viruses that must infect and replicate in cells lining the
nasopharynx of the recipient to induce immunity. Vaccine viruses capable of infection and replication can
be cultured from nasal secretions obtained from vaccine recipients (shedding).
Shedding of vaccine viruses within 28 days of vaccination was evaluated in 1) multi-center study
MI-CP129 which enrolled healthy individuals 6-59 months of age (N = 200); and 2) multi-center study
FM026 which enrolled healthy individuals 5-49 years of age (N = 344). In each study, nasal secretions were
obtained daily for the first 7 days and every other day through either Day 25 and on Day 28 or through
Day 28. In study MI-CP129, individuals with a positive shedding sample at Day 25 or Day 28 were to
have additional shedding samples collected every 7 days until culture negative on 2 consecutive samples.
Results of these studies are presented in Table 6.
Table 6 Characterization of Shedding in Specified Age Groups by Frequency, Amount, and Duration
Age
Number of
% Shedding
b
Peak Titer % Shedding Day of Last
Subjects (TCID50
/mL)
c
After Day 11 Positive Culture
6 - 23 months
a
99 89 < 5 log10
7.0 Day 23
d
24 - 59 months 100 69 < 5 log10
1.0 Day 25
e
5 - 8 years 102 50 < 5 log10
2.9 Day 23
f
9 - 17 years 126 29 < 4 log10
1.6 Day 28
f
18 - 49 years 115 20 < 3 log10
0.9 Day 17
f
a
FluMist is not approved for use in children <24 months of age [see Adverse Reactions (6)].
b
Proportion of subjects with detectable virus at any time point during the 28 days.
c
Peak titer at any time point during the 28 days among samples positive for a single vaccine virus.
d
A single subject who shed previously on Days 1-3; TCID50
/mL was less than 1.5 log10
on Day 23.
e
A single subject who did not shed previously; TCID50
/mL was less than 1.5 log10
.
f
A single subject who did not shed previously; TCID50
/mL was less than 1.0 log10
.
The highest proportion of subjects in each group shed one or more vaccine strains on Days 2-3 postvaccination. After Day 11 among individuals 2-49 years of age (n = 443), virus titers did not exceed
1.5 log10
TCID50
/mL.

ProQuad® 
Measles, Mumps, Rubella and Varicella Virus Vaccine Live  
Lyophilized preparation for subcutaneous injection (This package insert is from August 2011)



-CONTRAINDICATIONS-------------------------------
• History of anaphylactic reaction to neomycin or hypersensitivity to
gelatin or any other component of the vaccine. (4.1)
• Primary or acquired immunodeficiency states. (4.2)
• Family history of congenital or hereditary immunodeficiency. (4.2)
• Immunosuppressive therapy. (4.2, 7.3)
• Active untreated tuberculosis or febrile illness (>101.3°F
or >38.5°C). (4.3)
• Pregnancy. (4.4, 8.1, 17.1)
----------------------- WARNINGS AND PRECAUTIONS------------------------
• Administration of ProQuad (dose 1) to children 12 to 23 months
old who have not been previously vaccinated against measles,
mumps, rubella, or varicella, nor had a history of the wild-type
infections, is associated with higher rates of fever and febrile
seizures at 5 to 12 days after vaccination when compared to
children vaccinated with M-M-R® II and VARIVAX® administered
separately. (5.1, 6.1, 6.3)
• Use caution when administering ProQuad to children with a history
of cerebral injury or seizures or any other condition in which stress
due to fever should be avoided. (5.2)
• Use caution when administering ProQuad to children with
anaphylaxis or immediate hypersensitivity to eggs (5.3) or contact
hypersensitivity to neomycin. (5.4)

 ADVERSE REACTIONS ------------------------------
• The most frequent vaccine-related adverse events reported in
≥5% of subjects vaccinated with ProQuad were:
o injection-site reactions (pain/tenderness/soreness,
erythema, and swelling)
o fever
o irritability. (6.1)
• Systemic vaccine-related adverse events that were reported at a
significantly greater rate in recipients of ProQuad than in
recipients of the component vaccines administered concomitantly
were:
o fever
o measles-like rash. (6.1)
 
 In an open-label clinical trial, 699 healthy children 12 to 23 months of age were randomized to receive
2 doses of VAQTA® (hepatitis A vaccine, inactivated) (N=352) or 2 doses of VAQTA concomitantly with 2
doses of ProQuad (N=347) at least 6 months apart. An additional 1101 subjects received 2 doses of
VAQTA alone at least 6 months apart (non-randomized), resulting in 1453 subjects receiving 2 doses of
VAQTA alone (1101 non-randomized and 352 randomized) and 347 subjects receiving 2 doses of
VAQTA concomitantly with ProQuad (all randomized). The race distribution of the study subjects following
a dose of ProQuad was as follows: 47.3% White; 42.7% Hispanic; 5.5% other; 2.9% African-American;
and 1.7% Asian/Pacific. The gender distribution of the study subjects following a dose of ProQuad was
49.3% male and 50.7% female. Vaccine-related injection-site adverse reactions (days 1 to 5
postvaccination) and systemic adverse events (days 1 to 14 post VAQTA and days 1 to 28 post ProQuad
vaccination) observed among recipients of VAQTA and ProQuad administered concomitantly with VAQTA
at a rate of at least 1% are shown in Tables 5 and 6, respectively. In addition, among the randomized
cohort, in the 14 days after each vaccination, the rates of fever (including all vaccine- and
non-vaccine-related reports) were significantly higher in subjects who received ProQuad with VAQTA
concomitantly after dose 1 (22.0%) as compared to subjects given dose 1 of VAQTA without ProQuad
(10.8%). However, rates of fever  were not significantly higher in subjects who received ProQuad with
VAQTA concomitantly after dose 2 (12.5%) as compared to subjects given dose 2 of VAQTA without
ProQuad (9.4%). In post-hoc analyses, these rates were significantly different for dose 1 (RR 2.03 [95%
CI: 1.42, 2.94]), but not dose 2 (RR 1.32 [95% CI: 0.82, 2.13]). Rates of injection-site adverse reactions
and other systemic adverse events were lower following a second dose than following the first dose of
both vaccines given concomitantly. 

 8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Category C: Animal reproduction studies have not been conducted with ProQuad.
Do not administer ProQuad to pregnant females.  It is also not known whether ProQuad can cause
fetal harm when administered to a pregnant woman or can affect reproduction capacity. If vaccination of
post-pubertal females is undertaken, pregnancy should be avoided for 3 months following vaccination.
[See Contraindications (4.4).]
In counseling women who are inadvertently vaccinated when pregnant or who become pregnant within
3 months of vaccination, the healthcare provider should be aware of the following: (1) Reports have
indicated that contracting wild-type measles during pregnancy enhances fetal risk. Increased rates of
spontaneous abortion, stillbirth, congenital defects, and prematurity have been observed subsequent to
wild-type measles during pregnancy. There are no adequate studies of the attenuated (vaccine) strain of
measles virus in pregnancy. However, it would be prudent to assume that the vaccine strain of virus is
also capable of inducing adverse fetal effects; (2) Mumps infection during the first trimester of pregnancy
may increase the rate of spontaneous abortion. Although mumps vaccine virus has been shown to infect
the placenta and fetus, there is no evidence that it causes congenital malformations in humans;
5
 (3) In a
10-year survey involving over 700 pregnant women who received rubella vaccine within 3 months before
or after conception (of whom 189 received the Wistar RA 27/3 strain), none of the newborns had
abnormalities compatible with congenital rubella syndrome;
6
and (4) Wild-type varicella can sometimes
cause congenital varicella infection.
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., maintains a Pregnancy Registry to
monitor fetal outcomes of pregnant women exposed to varicella-containing vaccine (Oka/Merck). In the
first 9 years of the Pregnancy Registry for varicella vaccine (Oka/Merck), of 129 seronegative women and
423 women of unknown serostatus who received varicella vaccine during pregnancy or within 3 months
before pregnancy, none had newborns with abnormalities compatible with congenital varicella syndrome.
Patients and health care providers are encouraged to report any exposure to varicella-containing
vaccine (Oka/Merck) during pregnancy by calling 1-800-986-8999.
8.3 Nursing Mothers
Do not administer ProQuad to nursing women. It is not known whether ProQuad is excreted in human
milk. Because many drugs are excreted in human milk, caution should be exercised when ProQuad is
administered to a nursing woman. The secretion of measles and mumps viruses in human milk has not
been studied; however, studies have shown that lactating postpartum women vaccinated with live rubella
vaccine may secrete the virus in breast milk and transmit it to breast-fed infants. Limited evidence in the
literature suggests that virus, viral DNA, or viral antigen could not be detected in the breast milk of women
who were vaccinated postpartum with the vaccine strain of varicella virus.
7,8
[See Warnings and
Precautions (5.8).]
8.4 Pediatric Use
Do not administer ProQuad to infants younger than 12 months of age or to children 13 years and
older. Safety and effectiveness of ProQuad in infants younger than 12 months of age and in children 13
years and older have not been studied. ProQuad is not approved for use in persons in these age groups.
[See Adverse Reactions (6) and Clinical Studies (14).]
8.5 Geriatric Use
ProQuad is not indicated for use in the geriatric population (≥age 65)

 ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) is a combined, attenuated, live
virus vaccine containing measles, mumps, rubella, and varicella viruses. ProQuad is a sterile lyophilized
preparation of (1) the components of M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live):
Measles Virus Vaccine Live, a more attenuated line of measles virus, derived from Enders' attenuated
Edmonston strain and propagated in chick embryo cell culture; Mumps Virus Vaccine Live, the Jeryl
Lynn™ (B level) strain of mumps virus propagated in chick embryo cell culture; Rubella Virus Vaccine
Live, the Wistar RA 27/3 strain of live attenuated rubella virus propagated in WI-38 human diploid lung ProQuad®
Measles, Mumps, Rubella and Varicella Virus Vaccine Live 9950905
16
fibroblasts; and (2) Varicella Virus Vaccine Live (Oka/Merck), the Oka/Merck strain of varicella-zoster
virus propagated in MRC-5 cells. The cells, virus  pools, bovine serum, and human albumin used in
manufacturing are all tested to provide assurance that the final product is free of potential adventitious
agents.
ProQuad, when reconstituted as directed, is a sterile suspension for subcutaneous administration.
Each 0.5-mL dose contains not less than 3.00 log10 TCID50 of measles virus; 4.30 log10 TCID50
of mumps
virus; 3.00 log10 TCID50 of rubella virus; and a minimum of 3.99 log10 PFU of Oka/Merck varicella virus.
Each 0.5-mL dose of the vaccine contains no more than 21 mg of sucrose, 11 mg of hydrolyzed
gelatin, 2.4 mg of sodium chloride, 1.8 mg of sorbitol, 0.40 mg of monosodium L-glutamate, 0.34 mg of
sodium phosphate dibasic, 0.31 mg of human albumin, 0.17 mg of sodium bicarbonate, 72 mcg of
potassium phosphate monobasic, 60 mcg of potassium chloride; 36 mcg of potassium phosphate dibasic;
residual components of MRC-5 cells including DNA and protein; <16 mcg of neomycin, bovine calf serum
(0.5 mcg), and other buffer and media ingredients. The product contains no preservative. 





Thursday, April 12, 2012

Are You Contemplating Whether or Not You Want to Cloth Diaper?

I found a great article today about what things you should consider when you are thinking about using  cloth diapers. It really breaks it down with things such as ingredients in disposable diapers versus cloth diapers, cost of both kinds of diapers, washing cloth diapers and more! I also really like the section at the end where it spells it out about why cloth diapering just might not be for you!

Do You Ever Wish You Knew All You Know About Breastfeeding BEFORE You Began Breastfeeding?

As a first-time breastfeeding mom, it can be very overwhelming. You are feeding your baby ALL. THE. TIME. You wonder if you are feeding too often. You wonder if you are feeding often enough. You wonder if your baby is latched on appropriately. You wonder if baby is peeing enough. If baby is pooping enough. You wonder if you can manage it all. You wonder if your baby is really getting enough (after all, our breasts are not marked with ounces!).

Here is a fabulously written article JUST FOR YOU!

Wednesday, April 11, 2012

Looking for a more natural dental product?

A friend of mine tipped me off to this product after she consulted her dentist regarding gum bleeding issues she was having. He recommended this mouthwash. She says it has really helped. It says it is peppermint flavored, but she says it leans more towards a cinnamon flavor. Here is a link for it, which includes reviews:
http://www.drugstore.com/the-natural-dentist-healthy-gums-daily-oral-rinse-peppermint-twist/qxp160944

List of ingredients:
Active Ingredients: Aloe Vera (Aloe Barbadensis) Leaf Juice (Antigingivitis/Antiplaque)


Inactive Ingredients: Water (Purified), Vegetable Glycerin, Echinacea Angustifolia (Coneflower), Goldenseal, Calendula (Calendula Officinalis) Flower, Citric Acid, Natural Flavors (contains cinnamon oil), Grapefruit Seed Extract, Olivamidopropyl Betaine (sourced from olives), Potassium Citrate, Copper Chlorophylin

Want to win $200 Paypal Cash??

You have literally HUNDREDS of chances to win $200 Paypal cash from CouponTrade.com and The Ultimate Baby Shower!   CouponTrade.com is the newest and the hottest way to save because now, you can combine coupon savings with discounted gift cards for the same stores, plus sell all those unused gift cards and redeem whats yours, all in one place!!!   The Ultimate Baby Shower will offer MONTHLY diaper and Formula giveaways, as well as a seasonal NURSERY giveaway! That’s right- you can win the entire nursery, furniture, bedding, and all the baby gear you could need!   Entry is so simple, just fill out the Rafflecopter form below! a Rafflecopter giveaway

Parents - Newsletter For the Week of April 2nd


Just a reminder that all activities are based on the number of children present each day, ages of the children present, and mood of the children.




April Newsletter




Week of  April 2nd


Monthly Thematic Unit – Spring Has Sprung!


Color of the Month – Purple


Song of the Week:


“10 Little Bunnies“
(Sung to: "10 Little Indians")
1 little, 2 little, 3 little bunnies,
4 little, 5 little, 6 little bunnies,
7 little, 8 little, 9 little bunnies,
10 little bunnies hopping up and down.





Book of the Week: The Little Blue Easter Egg by Sarah Fisch


What We Did On Monday: We began our day by playing with our kitchen toys and building with our Duplo blocks. Then we enjoyed Independent Reading Time (IRT) where we focused this week on treating our books nicely to prevent them from ripping. After that, I introduced the BOTW and the SOTW. Later we played with our electronic learning toys, explored our Laugh and Learn Home, built with chain links, worked with our shape sorters, played in our dollhouse and drove our toy cars.


Special Enrichment for Monday: We played a Pom Pom Chicken Egg Hunt game where we hunted for eggs that had yellow poms poms inside, We talked about how chickens lays eggs. Sometimes the eggs have a double yolk and sometimes they are a dud and don't have a yolk at all! After we hunted for eggs, we opened them up and counted how many yolks we had. The child with the most yolks won!

We also went on a Nature Walk and had a Picnic Lunch down by the lake!


What We Did On Tuesday: We started our day off by playing with our toy cars and Little People playsets. Then we enjoyed IRT where we focused this week on treating our books nicely to prevent them from ripping. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our kitchen toys and dollhouse and built with our Legos.



Special Enrichment for Tuesday: We watched "It's the Easter Beagle, Charlie Brown!".


What We Did On Wednesday: We began our day by playing with our trains and building with our bristle blocks. Then we enjoyed IRT where we focused this week on treating our books nicely to prevent them from ripping. Then we read the BOTW and sang the SOTW. After that, we enjoyed playing with our slide, Laugh and Learn Home, building with our Lincoln Logs, and playing with our textured ball and Bounce Back Penguin.



Special Enrichment for Wednesday: We added some Easter eggs to the kitchen center and pretended to cook eggs! :)


What We Did On Thursday: We started our day by playing with our Laugh and Learn Home and indoor slide. Then we enjoyed IRT where we focused this week on treating our books nicely to prevent them from ripping. Then we sang the SOTW and read the BOTW. Later in the day, we also played with our Bounce Back penguin, kitchen toys, dinosaurs and trains.


Special Enrichment for Thursday: We sang and danced to our VeggieTales Cd!


What We Did On Friday: Closed in observance of Easter.


Special Enrichment for Friday: Closed in observance of Easter.


What We Did on Saturday: Closed in observance of Easter.


Special Enrichment on Saturday: Closed in observance of Easter.

Wednesday, April 4, 2012

Have Labors Gotten Longer In the Last Generation or Two?

An interesting thought process...how labors have changed since our Grandmothers' generation.

The typical first-time mother takes 6 1/2 hours to give birth these days. Her counterpart 50 years ago labored for barely four hours.

Lots of speculation about it in this article.

Are You Trying to Conceive Naturally But Want a Little Help?

We use Natural Family Planning when we choose to avoid pregnancy or to get pregnant. However, when it came down to trying to get pregnant with Daniella, we struggled. WE BOTH have an infertility issue. We began  trying to get pregnant with her in May 2007 and finally conceived her naturally (thanks to the help of chiropractic) in January 2010.

When we are ready to try for another one, we are concerned with it taking us a long time again. Therefore, we don't want to wait too long before trying again like when we tried for Daniella (Brandon was 5 1/2 when we started trying).

If you, like us, struggle a little with fertility, here is an article about some herbs that can be infused and taken to help!

Did You Know That You Can Save a TON of Money By Using Cloth Diapers???

Sure, they cost a pretty chunk of change up front....but in the end, you save a huge amount of money!! I just read a great article called The Benefits of Using Cloth Diapers and it really spells it out EXACTLY how much money you save!

Tuesday, April 3, 2012

Public Schools Aren't For Everyone

Those of you who know me personally know that I am a big advocate of school choice (My son attends a public charter school that us parents fought die-hard style for)...and while that *might* not quite fit the scope of my blog,  I still wanted to share this picture with you :)



New Winner Drawn for Teething Bling!

I did finally hear from the original winner, but even she acknowledged that she realized she was too late. :( Random.org had already generated a new winner, I just hadn't had a chance to post it yet. But here it is - Random.org chose post #29 - which is zooeycrazy! I have contacted her via FB PM at 1:30 PM EST so she has until Thursday at 1:30 pm to respond! :)


By the way, this may be a good time to remind you guys that at the top of my blog, there is a spot to sign up via email for notifications of new blog posts :) That might help some of you who aren't comfortable posting an email address publicly :) Or, you could get a "SPAM" type email address that you use just for things you sign up for :)

Monday, April 2, 2012

Got Spiders?

If you have the creepers in your house and want them out - here are some natural ways to deter spiders!

Artwork: Are You a Keeper, Tosser, Re-user or Recycler?

When our children are young, they bring home artwork ALL. THE. TIME! As a parent, you want to keep it all to remember and cherish those days. But there is only so much space!!!

I have known through my years in Early Childhood Education of a few things that parents have done.

1. I knew a family that for Christmas of their oldest child's Kindergarten year had a photo book made of the child's artwork, every piece that Mom had kept, from infancy through Pre-K. This way, Mom had a precious memento that allowed her to remember that time period while allowing her to let go of the actual artwork.

2. I knew another family who went out and bought 10 cheap 8x10 picture frames. These were then decorated 5 and 5 by the two children in the family. After they were decorated as the children wished, they were hung in the garage. Every week, each child chose 5 pieces of artwork to keep (the rest were recycled) to display in the frames for that week. At the end of the week, they were placed in a box marked with the child's name. At the end of each school year, the family hosts an "Art Gallery" night where the children are video-recorded showing off each piece of art and they talked about what the art is of, what inspired them, etc. (Mom made notes on the back each week as them were placed in the boxes to help the kids remember). After they were done being videoed, the art was then recycled while the video was kept as a memento.


Here is an article with MORE SUGGESTIONS!

What do YOU do with all of your child's artwork?

Interested in Composting?

I really want to compost. Coming up with the money for the ideal composting system though has hindered it from happening. I want a two bin system where one bin can be flipped into the other for easy turning/mixing. We'll see....someday!

Here is a great article with some info for people interested in composting!